A.De Mori
A.De Mori S.p.A. is a privately held, family-owned Italian medical device distributor founded in 1902 that specializes exclusively in Point of Care Testing, distributing a multi-vendor POCT portfolio (anchored by an exclusive Radiometer partnership) plus proprietary IT middleware to Italian hospitals, ICUs, and emergency departments.
- Company typePrivate
- Founded1902
- HeadquartersMilano, Italy
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What A.De Mori does
A. De Mori S.p.A. is a privately held, family-owned Italian medical device distributor founded in 1902 and headquartered in Milan, Italy. The company operates the "Ademori Group" with wholly owned subsidiaries ACDM and Astraformedic, specializing exclusively in Point of Care Testing (POCT) for decentralized diagnostics. It serves Italian hospitals, intensive care units (ICU, NICU), emergency departments, operating rooms, clinical laboratories, and territorial healthcare facilities through direct field sales, a national team of qualified technicians, and participation in major Italian scientific congresses (SIBioC, SIPMeL, ITACTA, AcEMC).
The company's core offering is a comprehensive, multi-vendor POCT portfolio that aggregates 12 diagnostic categories under a single-vendor relationship in Italy. This includes blood gas analyzers from Radiometer (ABL90 FLEX, ABL90 FLEX PLUS, ABL800 FLEX PLUS), a portable blood gas analyzer (Eaglenos EN-102), immunoassay (AQT90 FLEX), clinical chemistry (Piccolo Xpress, SimplexTAS 101), coagulation (OCG-102), hemostasis via Quantra SEER Sonorheometry, hematology (Icon 3/5), osmometry (Osmo1, OsmoPRO), urinalysis (Urilyzer 100 Pro, DOAC Dipstick), transcutaneous monitoring (PeriFlux 6000, TCM5 series), and micromethod testing (QuikRead go). A long-standing exclusive distribution partnership with Radiometer anchors the portfolio. Supporting products include proprietary sampling devices (safePICO syringes and capillaries) and an integrated IT stack (AQURE middleware, Ademori Suite with Tracking 4 You and Easy Report Web) that connects multi-vendor POCT fleets to hospital LIS/HIS systems via HL7, ASTM, and POCT1-A2 protocols.
Revenue is generated through three streams: (1) hardware sales of analyzers combined with recurring consumables, reagents, and single-use cartridges characteristic of the in-vitro diagnostics distribution model; (2) technical assistance including installation, preventive maintenance, remote teleservice, and 365-day support via a toll-free number; and (3) structured training and education services including on-site training, distance learning (FAD), and a dedicated e-learning platform. The company holds ISO 13485:2016, ISO 9001:2015, and Italian UNI PdR 125:2022 gender equality certifications. A. De Mori has 51-100 employees, remains entirely family-controlled with no external institutional funding, and operates with no publicly disclosed financials.
A.De Mori firmographics
Firmographics- Name
- A.De Mori
- Legal name
- A. De Mori S.p.A.
- Website
- https://ademori.it
- Company type
- Private
- Founded year
- 1902
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- A.De Mori S.p.A. is a privately held, family-owned Italian medical device distributor founded in 1902 that specializes exclusively in Point of Care Testing, distributing a multi-vendor POCT portfolio (anchored by an exclusive Radiometer partnership) plus proprietary IT middleware to Italian hospitals, ICUs, and emergency departments.
- Ownership category
- akta.pro rank
A.De Mori industry classification
Industry- Product category
- In-Vitro Diagnostics / Point of Care Testing
- NAICS
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450), Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Point-of-Care Testing (POCT) & Near-Patient Labs (HLAFAMAI)
- akta.pro secondary industries
- Blood Glucose & Metabolic POCT (Glucose, Ketones, Lactate) (HLAHAOAB), Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer) (HLAHAOAC)
Keywords
Where A.De Mori is headquartered
LocationHeadquarters
- HQ city
- Milano
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
A.De Mori business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Point of Care Diagnostic Equipment and Consumables: A. De Mori distributes a comprehensive portfolio of POCT diagnostic analyzers (blood gas, immunochemistry, coagulation, hematology, hemostasis, clinical chemistry, osmometry, urinalysis, transcutaneous monitoring) along with proprietary sampling devices (safePICO syringes, capillaries) and single-use reagent cartridges. Revenue is generated through the sale of instruments and recurring consumables/reagents, typical of the in-vitro diagnostics distribution model.
- Technical Assistance and Support Services: The company provides technical assistance including installation, testing, preventive maintenance, hardware/software interventions, and remote teleservice support. A nationwide team of qualified technicians ensures rapid response. Service is available every day including holidays via a toll-free number (800 275 309).
- Training and Education Services: A. De Mori offers structured training programs including traditional classroom training, distance learning (FAD), and an e-learning platform. Training is customized to customer needs and covers analytical systems and application software for healthcare operators.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
A.De Mori product offering
Product offeringCore offering
A. De Mori distributes and supports a comprehensive portfolio of Point of Care Testing (POCT) diagnostic analyzers, consumables and proprietary IT middleware across 12 diagnostic categories — including blood gas, immunochemistry, clinical chemistry, coagulation, hemostasis, hematology, osmometry, urinalysis and transcutaneous monitoring — for hospitals, ICUs, emergency departments and clinical laboratories throughout Italy. Revenue is generated through instrument sales, recurring reagent/consumable sales, technical assistance services and training programs.
Product overview
A. De Mori S.p.A. is an Italian company specializing in Point of Care Testing (POCT), offering a comprehensive portfolio of diagnostic solutions for decentralized healthcare diagnostics. The company's product ecosystem centers on blood gas analyzers (ABL90 FLEX, ABL90 FLEX PLUS, ABL800 FLEX PLUS, EAGLENOS EN-102), immunoassay testing (AQT90 FLEX), clinical chemistry (Piccolo Xpress, SimpleTAS 101), coagulation (OCG-102), hemostasis (Quantra), hematology (Icon 3, Icon 5), and osmometry (Osmo1, OsmoPRO). Supporting products include urine analysis systems (Urilyzer 100 Pro, DOAC Dipstick), transcutaneous monitors (PeriFlux 6000, TCM5 Basic, TCM5 Flex), micromethod diagnostics (QuikRead go), and specialized sampling devices (safePICO syringes and capillaries). The portfolio is unified through IT middleware solutions including AQURE for centralized POCT management and the Ademori Suite software (Tracking 4 You, Easy Report Web) for quality control and data interpretation. These products enable healthcare professionals to perform laboratory-quality diagnostics at the patient's bedside with full connectivity to hospital information systems.
Differentiator
Problem solved
Functional benefit
Products and services
- ABL90 FLEX Blood Gas Analyzer Point-of-care blood gas analyzer delivering 17 measured parameters in 35 seconds with only 65μL sample volume, designed for demanding hospital wards like ICU, NICU, and emergency departments.
- ABL90 FLEX PLUS Blood Gas Analyzer Advanced point-of-care blood gas analyzer providing 19 measured parameters including electrolytes, metabolites, and CO-Oximetry from syringe, capillary, or tube with 65μL blood in 35 seconds.
- ABL800 FLEX PLUS Blood Gas Analyzer High-volume blood gas analyzer with automated sample handling and Drop'n'go functionality, measuring 18 parameters for medium to high volume facilities in laboratory or Point of Care settings.
- EAGLENOS EN-102 Portable Blood Gas Analyzer Portable blood gas analyzer with microfluidic electrochemical technology, 11 measured parameters, results in about 4 minutes, requiring only 150μL sample. Ideal for emergency rooms, intensive care, anesthesia, cardiology, pulmonology, and emergency medicine.
- AQT90 FLEX Immunoassay Analyzer Point-of-care immunoassay analyzer for cardiac, coagulation, and infection biomarkers providing lab-quality results in 11-21 minutes. Tests include TnI, TnT, CKMB, Myo, NT-proBNP, PCT, CRP, D-Dimer, and βhCG.
- Piccolo Xpress Clinical Chemistry Analyzer Compact, automatic clinical chemistry analyzer with 31 tests across 16 comprehensive panels, featuring integrated Quality Control and maintenance-free operation for Point of Care settings.
- SimplexTAS 101 Clinical Chemistry Analyzer Next-generation clinical chemistry analyzer capable of performing up to 4 simultaneous tests with a single drop of blood. Measures CRP and HbA1c parameters with integrated centrifuge.
- OCG-102 Coagulation Analyzer Optical coagulation analyzer providing rapid laboratory quality results for PT/INR, APTT, TT, FIB and ACT tests. First POCT coagulation analyzer capable of testing these parameters, weighing only 850g.
- Quantra Hemostasis Analyzer Fully automated hemostasis analyzer using SEER Sonorheometry technology for point-of-care bleeding management. Provides 6 parameters with QPlus cartridge in ≤15 minutes and viscoelastic testing for improved patient outcomes.
- Icon 3 Hematology Analyzer 3-population hematology analyzer providing 22-parameter complete blood count with volumetric impedance method. Features 10.1 inch color LCD touch screen and extremely low reagent consumption.
- Icon 5 Hematology Analyzer 5-population hematology analyzer using laser-based flow cytometry with forward scattered light detection and volumetric impedance measurement, providing comprehensive 27-parameter blood count report.
- Osmo1 Osmometer Single sample osmometer using freezing point depression technology for osmolality measurement. Analyzes samples in 90 seconds with 20μL minimum sample volume, ideal for laboratories processing a dozen samples per day.
- OsmoPRO Osmometer Multi-sample osmometer with carousel device handling up to 20 samples, touchscreen interface, and industry-leading performance. Provides accurate analysis of patient samples ensuring maximum productivity.
- Urilyzer 100 Pro Urine Analyzer Semi-automatic urine test strip analyzer with integrated printer, managing up to 11 parameters. Features POCT connectivity, operator identification, and IT system connections for compliance and data acquisition.
- DOAC Dipstick Urine Diagnostic Test First point-of-care testing system for qualitative detection of direct oral anticoagulants (DOAC: Dabigatran, Apixaban, Edoxaban, Rivaroxaban) in human urine. Results available in 10 minutes via visual color identification or DOASENSE Reader.
- PeriFlux 6000 Transcutaneous Oxygen Monitor Transcutaneous oxygen monitor designed for evaluation of tissue oxygen and skin lesions in diabetic foot. Features automatic calibration, 2GB internal memory, and color touchscreen display.
- TCM5 Basic Transcutaneous Monitor Transcutaneous blood gas monitor for sleep diagnostics featuring dark screen, noise-free operation, and highly accurate sensors. Includes SpO2 detection by Masimo Set technology.
- TCM5 Flex Transcutaneous Monitor Continuous monitoring system for tcpO2, tcpCO2, SpO2 and heart rate in neonatal, intensive care, and respiratory illness settings. Delivers accurate measurements for critically ill patients.
- QuikRead go Point of Care Diagnostic System Next-generation POC system for CRP, HbA1c, and other tests. Compact instrument with integrated battery, touchscreen interface, and available tests including easy CRP, go CRP, go HbA1c, go Strep A, and go iFOBT.
- safePICO Blood Gas Sampling Syringes Pre-barcoded syringes with built-in mixing ball and dry electrolyte-balanced heparin for clot-free, homogeneous blood gas samples. Features integrated needle guard and safe tip cap for operator safety.
- safePICO Blood Gas Capillaries Capillary tubes for low-volume blood gas analysis with electrolyte-balanced heparin. Available in volumes from 35-210μL in safeCLINITUBE plastic format.
- AQURE POCT Middleware IT Solution Central Point of Care IT middleware solution for real-time management and control of POCT testing. Features include operator certification, QC management with peer comparison and Westgard rules, and FLEXLINK for bedside data registration.
- Ademori Suite — Tracking 4 You Web-based non-conformity management software for tracking issues within POCT analyzer networks. Automatically monitors sample registrations/acceptances and evaluates KPIs.
- Ademori Suite — Easy Report Web Interpretation aid software for blood gas analysis results displaying values and patient data on single screen. Automatically distinguishes disturbance types with possible causes.
- Technical Assistance and Maintenance Services Technical assistance services including installation, testing, preventive maintenance, hardware/software interventions, and remote teleservice support delivered by a nationwide team of qualified technicians, with a toll-free number (800 275 309) available every day including holidays.
- Training and Education Services Structured training programs for healthcare operators covering analytical systems and application software, delivered through traditional classroom training, distance learning (FAD), and an e-learning platform, customized to customer needs.
Quantifiable outcome
- ABL90 FLEX provides 17 measured parameters in 35 seconds from 65μL sample
- +4 more outcomes
Companies that use A.De Mori
Customer profileSegments3 records
Ideal customer profiles2 records
A.De Mori technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
Feature6 records
A.De Mori partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- RadiometercoreRadiometer is a globally leading manufacturer of blood gas, transcutaneous monitoring, and related POCT analyzers. A. De Mori is the exclusive distributor of Radiometer products in Italy. The partnership includes distribution of the ABL90 FLEX, ABL90 FLEX PLUS, ABL800 FLEX PLUS blood gas analyzers, AQT90 FLEX immunoassay analyzer, TCM transcutaneous monitors, and related sampling devices including safePICO syringes and capillaries.
- ACDM (Gruppo ACDM)minorACDM is a group company related to A. De Mori, sharing the Ademori Group corporate identity. It operates within the same diagnostic distribution ecosystem.
- AstraformedicminorAstraformedic is a group company within the Ademori Group, operating in the medical diagnostics sector.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
A.De Mori competitors and assessment
Company assessmentBroad incumbents
- QuidelOrtho: US-based rapid diagnostics specialist with overlapping presence in cardiac, infectious disease, and urinalysis POCT panels relevant to A. De Mori's immunoassay and urine product lines.
- Abbott (i-STAT / Alinity): Global diagnostics incumbent with broad POCT platform (i-STAT, Alinity) overlapping A. De Mori's blood gas and immunoassay offerings; competes at multinational hospital accounts across Europe.
- Siemens Healthineers (RAPIDPoint, epoc): Large IVD manufacturer with global POCT blood gas and immunoassay portfolio (RAPIDPoint, epoc); competitive overlap in central hospital and ED settings where A. De Mori installs its systems.
- bioMérieux: Global IVD company with growing decentralized testing franchises; competes broadly across clinical chemistry, microbiology, and immunoassay labs that A. De Mori's portfolio targets.
Direct peers
- Radiometer (Danaher): Global blood gas and POCT manufacturer whose products (ABL90 FLEX, ABL800, AQT90, TCM) A. De Mori exclusively distributes in Italy; direct technology and product overlap in the core POCT blood gas category.
- Werfen: Spain-headquartered IVD specialist in acute care diagnostics (blood gas, hemostasis, autoimmunity) with overlapping POCT portfolio; same hospital customer base and similar integrated instrument-plus-consumables model.
- Nova Biomedical: US-based POCT critical care analyzer manufacturer also partnered with A. De Mori in Italy; directly comparable product range (blood chemistry, glucose, lactate) serving ICU and ED customers.
Emerging players
- ELITech Group: European mid-market IVD company covering clinical chemistry, urinalysis, and POCT products; serves a similar decentralized testing use case at smaller scale and narrower geographic footprint.
Regional players
- Diapath: Italian pathology and diagnostics solutions provider; shares the Italian hospital laboratory customer base and competes in adjacent in-vitro diagnostic segments.
- Burker Group: Italian medical device and IVD distribution group serving hospitals and labs across Italy; comparable regional distribution model in overlapping medical technology categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
A.De Mori social profiles
Digital presenceA.De Mori compliance and trust
Trust signalCompliance3 records
A.De Mori financial estimates
Financial estimateRevenue estimate
Valuation estimate
A.De Mori leadership team
Management profileNumber of profiles
A.De Mori subsidiaries and ownership
Company hierarchySubsidiaries2 records
A.De Mori funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
A.De Mori M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about A.De Mori
What does A.De Mori do?
A. De Mori distributes and supports a comprehensive portfolio of Point of Care Testing (POCT) diagnostic analyzers, consumables and proprietary IT middleware across 12 diagnostic categories — including blood gas, immunochemistry, clinical chemistry, coagulation, hemostasis, hematology, osmometry, urinalysis and transcutaneous monitoring — for hospitals, ICUs, emergency departments and clinical laboratories throughout Italy. Revenue is generated through instrument sales, recurring reagent/consumable sales, technical assistance services and training programs.
Is A.De Mori a public or private company?
A.De Mori is a private company. It is classified as family owned and is currently operating.
When was A.De Mori founded?
A.De Mori was founded in 1902. It employs 51 to 100 people.
Where is A.De Mori based?
A.De Mori is headquartered in Milano, Italy, in the Europe region.
How does A.De Mori make money?
Three revenue lines are on record. Point of Care Diagnostic Equipment and Consumables are the primary driver. The others are technical Assistance and Support Services and training and Education Services.
Who are A.De Mori's main competitors?
Broad incumbents on record are QuidelOrtho, Abbott (i-STAT / Alinity), Siemens Healthineers (RAPIDPoint, epoc) and bioMérieux. Direct peers are Radiometer (Danaher), Werfen and Nova Biomedical. ELITech Group is listed as an emerging player. Regional players are Diapath and Burker Group.
Does A.De Mori have an API?
No public API is recorded for A.De Mori.
What industry is A.De Mori in?
A.De Mori's product category is In-Vitro Diagnostics / Point of Care Testing. Its primary akta.pro industry code is HLAFAMAI, Point-of-Care Testing (POCT) & Near-Patient Labs, with a secondary code of HLAHAOAB, Blood Glucose & Metabolic POCT (Glucose, Ketones, Lactate). Its NAICS code is 423450 and its SIC code is 5047.